Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane Induction in Advanced HNSCC
NCT00736944Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2008
- Primary completion
- Aug 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in head and neck squamous cell carcinoma (HNSCC), sponsored by Washington University School of Medicine. Started Dec 2008; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00736944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736944.